肿瘤患者化疗期血浆D-二聚体水平的分布

Distribution of plasma D-Dimer in cancer patients during chemotherapy

  • 摘要: 目的 了解化疗期间血浆D-二聚体的浓度随化疗变化的趋势和特点,为排除肿瘤并发的静脉血栓提供依据。 方法 将101例化疗患者分为胃癌、肠癌、肺癌三组,以自动化乳胶比浊法定量检测患者血浆D-二聚体的浓度,并以广义线性模型进行重复测量资料的方差分析,判断肿瘤类型和化疗时间对D-二聚体浓度的影响。 结果 胃癌与肠癌、肺癌之间差异有统计学意义(P<0.05),后两者之间差异无统计学意义,单一病种化疗的不同时期D-二聚体浓度差异无统计学意义(F=1.358,P>0.05),肿瘤类型与化疗时间对D-二聚体变化无联合作用(F=0.565,P>0.05)。 结论 肿瘤患者D-二聚体的变化不受化疗因素影响;不同肿瘤类型之间D-二聚体的差异提示可建立各组临界值,作为预后参照。

     

    Abstract: Objective To provide the evidence for excluding venous thromboembolism in patients with cancer during chemotherapy by investigating the change in their plasma D-Dimer concentration. Methods One hundred and one patients were divided into gastric cancer group,intestinal cancer group,and lung cancer group.Their plasma D-Dimer concentrations were measured by automatic immuno-turbidimetric assay and analyzed by ANOVA test in a general linear model. Results A significant difference was found in plasma D-Dimer concentration of patients with gastric,intestinal and lung cancer(F=8.634,P<0.05).However,no significant difference was found in plasma D-Dimer concentration of patients with gastric and intestinal cancer or with a single cancer(F=1.358,F=0.565,P>0.05).Cancer type and chemotherapy time had no combined action on plasma D-Dimer concentration(P>0.05). Conclusion Chemotherapy does not influence the plasma D-Dimer concentration in cancer patients.The difference in plasma D-Dimer level among different types of cancer suggests that the critical plasma D-Dimer cutoff value should be established for the prognosis of such cancer patients.

     

/

返回文章
返回